Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Factor | p | OR | 95% CI | p | OR | 95% CI |
Gender (male vs. female) | 0,188 | 0,79 | 0,55–1,12 | |||
Age (years) (<54 vs. ≥55) | 0,001 | 1,65 | 1,22–2,22 | 0,043 | 1,4 | 1,01–1,93 |
Disease duration (years) (<5 vs. ≥5) | 0,073 | 0,75 | 0,55–1,02 | |||
T stadium (T1 and T2 vs. T3 and T4) | 0,337 | 0,86 | 0,64–1,16 | |||
N stadium (N0 and Nx vs. N1a and N1b) | 0,438 | 0,70 | 0,29–1,71 | |||
Tumor type (minimally vs. widely invasive) | 0,485 | 0,89 | 0,65–1,22 | |||
Tumor size (mm) (≤39 vs. >40) | 0,723 | 1,06 | 0,77–1,44 | |||
Capsular invasion (positive vs. no or minimal) | 0,001 | 1,71 | 1,23–2,37 | 0,007 | 1,59 | 1,13–2,22 |
Vascular invasion (positive vs. no or minimal) | 0,002 | 1,64 | 1,19–2,23 | |||
Number of tumor focuses (one vs. multicentric) | 0,364 | 0,84 | 0,58–1,22 | |||
Affection of both lobes (yes vs. no) | 0,123 | 1,33 | 0,92–1,9 | |||
Regional tumor infiltration (yes vs. no) | 0,19 | 1,37 | 0,86–2,18 | |||
Primary procedure (total thyroidectomy vs. less than total) | 0,335 | 1,18 | 0,84–1,63 | |||
Type of procedure overall (total thyroidectomy vs. less than total) | 0,254 | 1,22 | 0,86–1,71 | |||
Surgeon’s experience (years) (<10 vs. 10+) | 0,001 | 0,58 | 0,42–0,79 | 0,003 | 0,62 | 0,44–0,85 |
Radioiodine ablation (yes vs. no) | 0,026 | 0,69 | 0,49–0,95 | |||
Diabetes mellitus (yes vs. no) | 0,097 | 0,59 | 0,32–1,09 | |||
Hypertension (yes vs. no) | 0,009 | 0,67 | 0,5–0,9 | |||
Other malignancies (yes vs. no) | 0,001 | 0,45 | 0,27–0,73 | 0,034 | 0,58 | 0,35–0,96 |
Thyroglobulin (ng/mL) (<300 vs. >300) | 0,976 | 1,01 | 0,55–1,83 |